Scientific ReportsCancer BiologyPeer-reviewed journal article
The Ubiquitin-Proteasome System is an Important Driver of EBV-Associated Nasopharyngeal Carcinoma Progression: A Meta-Analysis of Transcriptomics Data
Hana RatnawatiiD, Ardo SanjayaiD, Aldrich Christiandy, Lawrence Young, Sascha OttiD
Abstract
BackgroundEpstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC) is characterized by extensive immune infiltration, yet immune evasion remains a hallmark of the disease. In this study, we aimed to leverage publicly available datasets to identify EBV-host gene interactions and re-map their expression at single-cell resolution. MethodsWe conducted a meta-analysis of transcriptomic datasets to identify differentially expressed genes in NPC, mapped these genes to EBV-host interaction data, and constructed a network. Network clustering and pathway enrichment were performed, and single-cell RNA sequencing datasets were used to map these genes at cellular resolution. We analysed differences in cell cycle, immune signaling, cell-cell interactions, and assessed prognostic associations of a 12-gene UPS signature using the GEPIA2 platform. ResultsWe identified 85 EBV-interacting DEGs, most regulated by lytic-phase proteins. MCODE clustering highlighted genes related to the ubiquitin-proteasome system (UPS). Single-cell analyses confirmed elevated UPS-related gene expression in NPC compared to EBV-negative oropharyngeal cancer. UPS-High cells exhibited lower proliferative activity, enriched stemness signaling, and reduced antigen presentation and immune activation, whereas UPS-Low cells showed marked upregulation of growth-promoting pathways. Survival analysis revealed that high UPS expression was associated with poorer outcomes in both pan-cancer and head and neck squamous cell carcinoma datasets. The proportion of UPS-High cells varied widely across patients. ConclusionUPS activity, influenced by EBV lytic proteins, is linked to immune evasion, stemness, proliferation, and adverse prognosis. These findings support UPS as a potential biomarker and therapeutic target in EBV-associated NPC, warranting NPC-specific validation and functional studies. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=129 SRC="FIGDIR/small/673297v1_ufig1.gif" ALT="Figure 1"> View larger version (21K): org.highwire.dtl.DTLVardef@14032bborg.highwire.dtl.DTLVardef@1c2b995org.highwire.dtl.DTLVardef@126185eorg.highwire.dtl.DTLVardef@9c5f6_HPS_FORMAT_FIGEXP M_FIG C_FIG EBV-driven ubiquitin-proteasome dysregulation in nasopharyngeal carcinoma revealed by bulk and single-cell transcriptomics, linked to immune evasion and poor survival.
- organism: human
- assay: bulk RNA-seq
- assay: scRNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: protein structure prediction
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 5th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EPSTEIN-BARR VIRUS LMP1 ENHANCES LEVELS OF MICROVESICLE-ASSOCIATED PD-L1
D. G. Meckes, M. A. Harb, L. Sun·bioRxiv·Jan 14, 2022
- EBV LMP1-activated mTORC1 and mTORC2 Coordinately Promote Nasopharyngeal Cancer Stem Cell Properties
- Epstein-Barr viral product-containing exosome facilitates LIF-associated immunosuppressive polarization of macrophage in nasopharyngeal carcinoma
Tzu-Tung Liu, Kai‐Ping Chang, … Shu‐Chen Liu·Cancer LettersPeer-reviewed·Oct 14, 2026
- A three-dimensional Air-Liquid Interface Culture Model for the Study of Epstein-Barr virus Infection in the Nasopharynx
P. Ziegler, Y. Bai, … K. H. Y. Shair·bioRxiv·Aug 31, 2020
- Acyclovir Improves the Efficacy of Chemoradiation in Nasopharyngeal Cancer Containing the Epstein Barr Virus Genome
A. Thandoni, A. Zloza, … S. R. Jhawar·bioRxiv·Oct 18, 2020
- EBNA1 INHIBITORS REVEAL CDC7 AND POU2F1 AS DIRECT FUNCTIONAL TARGETS IN EBV EPITHELIAL CANCERS
Songtao He, Niseno Terhuja, … Paul M. Lieberman·mBioPeer-reviewed·May 14, 2026